Cannabis Law Report

OCTOBER 15, 2021

The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e., New data supporting the use of machine learning and electronic health records to predict DN in patients with diabetes. “In

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. in 2021 reached $2 billion, according to Statistica.)

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JULY 13, 2021

As the psychedelic renaissance contributes to a swelling pool of safety and efficacy data pertaining to the potential therapeutic benefits of psychedelic medicine, many localities—particularly in North America—are revising their legal frameworks. Last updated: July 4th, 2021. This is what they are saying.

Decriminalization 105

Decriminalization Legalization Data Safety 105

Cannabis Law Report

AUGUST 23, 2021

& Notice of 2021 Final Results. . After confirmation of 6-months stability of tech-transfer batch, the work has been initiated, with preliminary data packages available by the second half of September, well within the proposed timelines. Pre-Close Trading Update; US OTC QB Market Application. & Since the year-end, the £2.6

Cannabinoids 98

Cannabinoids Research and Development Clinical Trials Packaging 98

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JUNE 1, 2021

TORONTO, June 01, 2021 (GLOBE NEWSWIRE) — via InvestorWire – RYAH Group, Inc. We are pleased to bring RYAH’s IoT device and integrated data solutions to the United Kingdom, providing a new level of session accuracy, patient feedback consistency, and data integrity to the clinical framework in plant-based medicine research.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

MAY 16, 2022

Data on injured workers from the nation’s most mature adult-use cannabis market is pretty boring. It has been 10 years since Colorado legalized recreational cannabis, and 22 years following legalization of medicinal use. He expected to see correlations in the data pointing to dates like April 20, with potentially more impaired workers.

Data 52

Data Strains Safety Cultivation 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

AUGUST 12, 2021

Czech Republic August 11 2021. Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. This regulative environment also promotes economic growth and significant medical benefits, boosting consumer safety and accessibility.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

JULY 8, 2022

“Individual, licensed laboratories use different methods which may produce inconsistent results and inaccurate data on cannabis cannabinoid content. Senate Bill (SB) 544 (Laird, 2021) requires DCC to establish standardized cannabinoid test methods by January 1, 2023.

Cannabinoids 59

Cannabinoids Safety Packaging Cannabis 59

Cannabis Law Report

SEPTEMBER 15, 2021

More than 100 people in the US have been hospitalized in 2021 after using Delta-8 THC products, federal health regulators warned Tuesday. National poison control centers received 661 exposure cases of delta-8 THC products between January 2018 and July 31, 2021, 660 of which occurred between January 1, 2021, and July 31, 2021.

THC 105

THC Pets Events Hemp 105

Veriheal

AUGUST 14, 2023

The directive from Mastercard underscores the contradictory landscape of cannabis laws in the United States, where cannabis is legal for medicinal and recreational use in most states yet remains illegal under federal law. In 38 states , cannabis has been legalized to varying degrees for medicinal and recreational use.

Banking 98

Banking Dispensary Cannabis Recreational 98

Cannabis Law Report

SEPTEMBER 23, 2021

Toronto, Ontario, Sep 23, 2021 (Newsfile Corp via COMTEX) — Toronto, Ontario–(Newsfile Corp. – September 23, 2021) – Awakn Life Sciences Corp., (NEO: – September 23, 2021) – Awakn Life Sciences Corp., (NEO: Imperial College London is one of the world’s leading universities.

Research and Development 52

Research and Development Therapy Treatment Data 52

Veriheal

JUNE 6, 2023

Athletes Have Long Been Disqualified for Cannabis Use A similar sanction happened to a high-profile American athlete in 2021. Olympic trials in 2021, when Sha’Carri Richardson was banned from the Olympics, there has been quite some debate on whether cannabis should be on the list of banned substances. Since the U.S. The post U.S.

THC 98

THC Recreational Decriminalization Sleep 98

SpeedWeed

JULY 25, 2021

Here are the applicants and their scores with notable MSO losses in red text: Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media. Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media.

Media 52

Media Data Dispensary Access 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 25, 2021

24 June 2021. According to the federal government, the Cannabis Act’s three stated objectives are to (i) keep cannabis out of the hands of young people, (ii) keep profits out of the pockets of criminals, and (iii) protect public health and safety by allowing adults to access legal cannabis. Torkin Manes LLP. with the authors.

Cannabinoids 91

Cannabinoids Edibles Retail Cannabis 91

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. Last week in Nature Medicine , I.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

MAY 26, 2022

was published in the Journal of Safety Research and made available online on May 18. Journal of Safety Research. Currently (as of July 1, 2021), 19 states and the District of Columbia have officially legalized both medical and recreational marijuana use. To Read The Rest Of This Article On High Times, Click Here.

Dispensary 52

Dispensary Research and Development Safety Recreational 52

Cannabis Law Report

JULY 1, 2021

July 1, 2021 – Jushi Holdings Inc. These and the other public and patient safety protections authorized during the COVID emergency will help us and the industry generally protect a medically vulnerable population of Pennsylvanians. BOCA RATON, Fla., of House members.

Programs 85

Programs Supply Chain Research and Development Marijuana 85

Cannabis Law Report

DECEMBER 11, 2021

The clinic established the UK Medical Cannabis Registry to offer patients medical cannabis products at a reduced price while collecting and analysing clinical data from real-world evidence “to expand our understanding of medical cannabis in the UK”. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Veriheal

AUGUST 3, 2021

Mainly, the measure protects patient safety and amplifies product quality requirements, all the while entrusting the state’s Medical Marijuana Advisory Board to consider broadening the program’s list of qualifying medical conditions. million in recorded sales revenue from April 2020 to March 2021.

Legislation 98

Legislation Patients Supply Chain Dispensary 98

SpeedWeed

MARCH 12, 2021

That’s what the data shows around the country. And that’s going to put people at risk: when you go around regulations that are designed for the health and safety of our society.”. Anna Wishart that would legalize the medicinal use of cannabis. This is a dangerous drug that will impact our kids. Medical Marijuana Bill Pending.

Marijuana 52

Marijuana Medicine Data Safety 52

Cannabis Law Report

DECEMBER 9, 2021

The Financing is expected to close on December 10, 2021. Dr. Johnson recently reported his interim results at Microdose’s Psychedelic Medicine Business Event, from his current smoking cessation study, utilizing a single macro-dose of psilocybin. DENVER, Dec. DENVER, Dec. Matthew Johnson. Advancements in IP and Drug Development.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

SpeedWeed

JULY 4, 2021

The US Food and Drug Administration’s (FDA) Center for Veterinary Medicine sounded the alarm on Thursday—pleading with pet owners to avoid using unregulated cannabidiol (CBD) products for dogs dealing with anxiety due to scary fireworks noises. FDA CVM (@FDAanimalhealth) July 1, 2021.

Pets 52

Pets CBD Food Hemp 52

The Cannigma

JANUARY 13, 2023

For example, researchers at Hopkins Medicine point to changes in chemical compounds like CGRP , serotonin and hormones like estrogen affecting pain levels. Like many conditions that modern medicine falls short of treating, migraines are now suspected to be a possible problem of endocannabinoid system deficiency in some patients.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

AUGUST 17, 2021

Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. We believe the totality of the data is encouraging and supports advancing to Phase 3. Data Highlights. Food and Drug Administration (FDA) has granted orphan drug designation to ganaxolone in TSC. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

DECEMBER 1, 2021

2 December 2021. For the study, researchers pooled data from 28 publications involving consumption of either ingested or inhaled forms of cannabis. This is a particularly pressing problem for the rapidly increasing number of patients in Australia who are using legal medicinal cannabis yet are prohibited from driving.

THC 52

THC Research and Development Concentrates Cannabinoids 52

Cannabis Law Report

DECEMBER 14, 2021

(NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer pen products in a UK-based manufacturing premises, licensed and approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Home Office.

Extraction 52

Extraction Patients Medicine Tincture 52

Cannabis Law Report

MAY 29, 2022

In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] 4] In April 2021, a separate study from the New England Journal of Medicine demonstrated the efficacy of psilocybin in reducing symptoms of depression. [5] 1025, 1025 (2021). [5] Mitchell et al.,

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Canna Law Blog

DECEMBER 16, 2021

On Monday, November 13, 2021, New York Assemblyman Pat Burke introduced medical psilocybin legislation. Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research.

Legislation 97

Legislation Treatment Therapy Conditions 97

Veriheal

AUGUST 31, 2020

These students showed knowledge and passion for the future of cannabis and posed revolutionary ideas rooted in their training across business, agriculture, biochemistry, public health, pharmacology, medicine, and liberal arts. . Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. published the first edition of the MAPS Bulletin , titled “ MDMA Can Become a Legal Medicine ,” and the FDA rejected the second MDMA study protocol submitted by MAPS. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Cannigma

JULY 9, 2023

7 Despite concerns about cannabis and cognition, a 2021 review of the evidence found little connection between early cannabis use and negative effects on brain development. A 2022 systematic review and meta-analysis that reviewed data from approximately 5.5 Does consuming cannabis while breastfeeding affect the baby?

Research and Development 68

Research and Development THC Cannabinoids Topical 68

Cannabis Law Report

MAY 12, 2022

State policymakers and public lawyers now confront the challenge of developing licensing schemes and regulatory rules to protect public health and safety, designing effective tax rates and business structures, and advancing equitable goals ranging from expunging old convictions to helping disadvantaged communities participate in the industry.

Law 52

Law Policy State Laws Environment 52

Cannabis Law Report

JULY 28, 2021

– July 28, 2021) – PharmaDrug Inc. The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. Toronto, Ontario–(Newsfile Corp.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105